Captodiame: Difference between revisions
CSV import |
CSV import Tags: mobile edit mobile web edit |
||
| Line 24: | Line 24: | ||
{{stub}} | {{stub}} | ||
== Captodiame == | |||
<gallery> | |||
File:Captodiame.svg|Structure of Captodiame | |||
File:Captodiamine_synthesis.png|Synthesis of Captodiame | |||
</gallery> | |||
Latest revision as of 01:50, 17 February 2025
Captodiame is a sedative and anxiolytic drug in the benzodiazepine class. It is known for its antihistamine properties and is used primarily in France for the treatment of anxiety and insomnia, as well as for sedation in minor surgical procedures.
Pharmacology[edit]
Captodiame is a benzodiazepine, a class of drugs that are known for their sedative and anxiolytic effects. It works by enhancing the effect of the neurotransmitter gamma-aminobutyric acid (GABA) in the brain, which results in a calming effect. Captodiame also has antihistamine properties, which can help to reduce symptoms of allergies.
Medical Uses[edit]
Captodiame is primarily used for the treatment of anxiety and insomnia. It can also be used for sedation in minor surgical procedures. It is not typically used for long-term treatment, as it can lead to dependence and withdrawal symptoms.
Side Effects[edit]
Like other benzodiazepines, captodiame can cause a number of side effects. These can include drowsiness, dizziness, confusion, and impaired coordination. It can also cause more serious side effects such as memory loss, depression, and dependence.
Interactions[edit]
Captodiame can interact with a number of other medications, including other benzodiazepines, opioids, and alcohol. These interactions can increase the risk of side effects and can be potentially dangerous.


